SAR-135966

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug NameSAR-135966
Drug Alias Nameneuropeptide Y1 antagonist (sanofi-aventis/Cerep)SAR-135966CER-002400
ClassificationSmall molecules
Mechanisms of ActionNeuropeptide Y receptor type 1 antagonists
TargetsNeuropeptide Y receptor type 1
Therapy Area/IndicationsDiabetes Mellitus, Type 2
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryFrance
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesCerephex Co
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesCerephex CoSanofi
Active IndicationsN/A
Inactive IndicationsDiabetes Mellitus, Type 2

Other Information

ATC CodeN/A
Related LinksN/A